Pflügers Archiv - European Journal of Physiology

, Volume 470, Issue 11, pp 1691–1703 | Cite as

The renal vasodilatory effect of prostaglandins is ameliorated in isolated-perfused kidneys of endotoxemic mice

  • Manuel Meurer
  • Katharina Ebert
  • Frank Schweda
  • Klaus HöcherlEmail author
Organ Physiology
Part of the following topical collections:
  1. Organ Physiology


Endotoxemia-related acute kidney injury (AKI) is associated with increased formation of prostaglandins, which may serve as a compensatory mechanism to maintain renal function. We hypothesized that an increase of renal EP2 or EP4 receptors and/or a downregulation of renal EP1 and EP3 receptors enhances PGE2-induced renal vasodilatation. Injection of lipopolysaccharide (LPS; 3 mg/kg i.p.) increased microsomal prostaglandin E synthase (mPGES)-1 and prostacyclin synthase expression, whereas mPGES-2 expression was unaltered. Further, LPS increased the mRNA abundance for the prostaglandin EP4 receptor, whereas the expressions of the EP1 and EP3 receptors were decreased. In isolated-perfused kidneys from control mice, PGE2 exerted a dual effect on renal vascular tone, inducing vasodilatation at lower concentrations and vasoconstriction at higher concentrations. In kidneys from endotoxemic mice, the vasodilatory component was more pronounced, whereas the vasoconstriction at higher PGE2 concentrations was absent. Similarly, prostacyclin (PGI2)-induced vasodilatation was more pronounced in endotoxemic kidneys. The enhanced vasodilatory effect was paralleled by an increase in renal vascular EP4 and prostacyclin IP receptor mRNA expression. Further, stimulation of renin secretion rate by PGE2 and PGI2 was enhanced in endotoxemic kidneys. Pretreatment with the cyclooxygenase (COX)-2 inhibitor SC-236 (10 mg/kg) did not alter the basal GFR, but augmented the LPS-induced decline in GFR, and attenuated the LPS-induced increase in plasma renin concentration in vivo. Our data suggest that an activation of the COX-2/mPGES-1 synthetic pathway is responsible for the increased renal formation of PGE2 in response to LPS and that the vasodilatory effect of PGE2 and PGI2 is enhanced during endotoxemia.


Prostaglandin Prostacyclin Endotoxemia Cyclooxygenase Renal vascular tone Renin 



The technical assistance provided by Ramona Mogge is gratefully acknowledged.

Funding information

This study was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, SFB699/B5).

Compliance with ethical standards

All animal experiments were conducted according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the local animal protection committee.


  1. 1.
    Hao CM, Breyer MD (2008) Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol 70:357–377. CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Brater DC (2002) Renal effects of cyclooxygyenase-2-selective inhibitors. J Pain Symptom Manag 23:S15–S20 discussion S21–3CrossRefGoogle Scholar
  3. 3.
    Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310:563–572. CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Ciabattoni G, Cinotti GA, Pierucci A, Simonetti BM, Manzi M, Pugliese F, Barsotti P, Pecci G, Taggi F, Patrono C (1984) Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N Engl J Med 310:279–283. CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Tang L, Loutzenhiser K, Loutzenhiser R (2000) Biphasic actions of prostaglandin E(2) on the renal afferent arteriole : role of EP(3) and EP(4) receptors. Circ Res 86:663–670CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Eskildsen MP, Hansen PB, Stubbe J, Toft A, Walter S, Marcussen N, Rasmussen LM, Vanhoutte PM, Jensen BL (2014) Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors. Hypertension 64:551–556. CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Schweda F, Klar J, Narumiya S, Nusing RM, Kurtz A (2004) Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys. Am J Physiol Renal Physiol 287:F427–F433. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Morath R, Klein T, Seyberth HW, Nusing RM (1999) Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. J Am Soc Nephrol 10:1851–1860PubMedPubMedCentralGoogle Scholar
  9. 9.
    Komhoff M, Lesener B, Nakao K, Seyberth HW, Nusing RM (1998) Localization of the prostacyclin receptor in human kidney. Kidney Int 54:1899–1908. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Perner A, Cecconi M, Cronhjort M, Darmon M, Jakob SM, Pettila V, van der Horst ICC (2018) Expert statement for the management of hypovolemia in sepsis. Intensive Care Med 44:791–798. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801–810. CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Opal SM (2010) Endotoxins and other sepsis triggers. Contrib Nephrol 167:14–24. CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Levy B, Fritz C, Tahon E, Jacquot A, Auchet T, Kimmoun A (2018) Vasoplegia treatments: the past, the present, and the future. Crit Care 22:52. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Schmidt C, Hocherl K, Kurt B, Bucher M (2008) Role of nuclear factor-kappaB-dependent induction of cytokines in the regulation of vasopressin V1A-receptors during cecal ligation and puncture-induced circulatory failure. Crit Care Med 36:2363–2372. CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Schmidt C, Hocherl K, Kurt B, Moritz S, Kurtz A, Bucher M (2010) Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock. Cytokine 49:30–38. CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Schmidt C, Kurt B, Hocherl K, Bucher M (2009) Inhibition of NF-kappaB activity prevents downregulation of alpha1-adrenergic receptors and circulatory failure during CLP-induced sepsis. Shock 32:239–246. CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hocherl K, Dreher F, Kurtz A, Bucher M (2002) Cyclooxygenase-2 inhibition attenuates lipopolysaccharide-induced cardiovascular failure. Hypertension 40:947–953CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Hocherl K, Schmidt C, Kurt B, Bucher M (2008) Activation of the PGI(2)/IP system contributes to the development of circulatory failure in a rat model of endotoxic shock. Hypertension 52:330–335. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Szabo C, Southan GJ, Thiemermann C (1994) Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci U S A 91:12472–12476CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351:159–169. CrossRefGoogle Scholar
  21. 21.
    Lipcsey M, Bellomo R (2011) Septic acute kidney injury: hemodynamic syndrome, inflammatory disorder, or both? Crit Care 15:1008. CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, Bagshaw SM, Glassford NJ, Lankadeva Y, Vaara ST, Schneider A (2017) Acute kidney injury in sepsis. Intensive Care Med 43:816–828. CrossRefGoogle Scholar
  23. 23.
    van Lambalgen AA, Bouriquet N, Casellas D (1996) Effects of endotoxin on tone and pressure-responsiveness of preglomerular juxtamedullary vessels. Pflugers Arch 432:574–577CrossRefPubMedCentralGoogle Scholar
  24. 24.
    Lugon JR, Boim MA, Ramos OL, Ajzen H, Schor N (1989) Renal function and glomerular hemodynamics in male endotoxemic rats. Kidney Int 36:570–575CrossRefPubMedCentralGoogle Scholar
  25. 25.
    Van Beusecum JP, Zhang S, Cook AK, Inscho EW (2017) Acute toll-like receptor 4 activation impairs rat renal microvascular autoregulatory behaviour. Acta Physiol (Oxf) 221:204–220. CrossRefGoogle Scholar
  26. 26.
    El-Achkar TM, Huang X, Plotkin Z, Sandoval RM, Rhodes GJ, Dagher PC (2006) Sepsis induces changes in the expression and distribution of toll-like receptor 4 in the rat kidney. Am J Physiol Renal Physiol 290:F1034–F1043. CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Bucher M, Kees F, Taeger K, Kurtz A (2003) Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med 31:566–571. CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Yamaguchi N, Jesmin S, Zaedi S, Shimojo N, Maeda S, Gando S, Koyama A, Miyauchi T (2006) Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat. Peptides 27:2258–2270. CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Boffa JJ, Arendshorst WJ (2005) Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock. J Am Soc Nephrol 16:117–124. CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Hocherl K, Schmidt C, Bucher M (2009) COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex. Kidney Int 75:373–380. CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Boulet L, Ouellet M, Bateman KP, Ethier D, Percival MD, Riendeau D, Mancini JA, Methot N (2004) Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile. J Biol Chem 279:23229–23237. CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang D (1993) Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys 307:361–368CrossRefPubMedCentralGoogle Scholar
  33. 33.
    Hirata M, Hayashi Y, Ushikubi F, Yokota Y, Kageyama R, Nakanishi S, Narumiya S (1991) Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 349:617–620. CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Boffa JJ, Just A, Coffman TM, Arendshorst WJ (2004) Thromboxane receptor mediates renal vasoconstriction and contributes to acute renal failure in endotoxemic mice. J Am Soc Nephrol 15:2358–2365. CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Mederle K, Meurer M, Castrop H, Hocherl K (2015) Inhibition of COX-1 attenuates the formation of thromboxane A2 and ameliorates the acute decrease in glomerular filtration rate in endotoxemic mice. Am J Physiol Renal Physiol 309:F332–F340. CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Johannes T, Ince C, Klingel K, Unertl KE, Mik EG (2009) Iloprost preserves renal oxygenation and restores kidney function in endotoxemia-related acute renal failure in the rat. Crit Care Med 37:1423–1432. CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Wang W, Zolty E, Falk S, Summer S, Stearman R, Geraci M, Schrier R (2007) Prostacyclin in endotoxemia-induced acute kidney injury: cyclooxygenase inhibition and renal prostacyclin synthase transgenic mice. Am J Physiol Renal Physiol 293:F1131–F1136. CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Henrich WL, Hamasaki Y, Said SI, Campbell WB, Cronin RE (1982) Dissociation of systemic and renal effects in endotoxemia. Prostaglandin inhibition uncovers an important role of renal nerves. J Clin Invest 69:691–699CrossRefPubMedCentralGoogle Scholar
  39. 39.
    Yang T, Singh I, Pham H, Sun D, Smart A, Schnermann JB, Briggs JP (1998) Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Phys 274:F481–F489CrossRefGoogle Scholar
  40. 40.
    Hocherl K, Schmidt C, Kurt B, Bucher M (2010) Inhibition of NF-kappaB ameliorates sepsis-induced downregulation of aquaporin-2/V2 receptor expression and acute renal failure in vivo. Am J Physiol Renal Physiol 298:F196–F204. CrossRefPubMedGoogle Scholar
  41. 41.
    Schmidt C, Hocherl K, Schweda F, Bucher M (2007) Proinflammatory cytokines cause down-regulation of renal chloride entry pathways during sepsis. Crit Care Med 35:2110–2119CrossRefPubMedCentralGoogle Scholar
  42. 42.
    Zarjou A, Agarwal A (2011) Sepsis and acute kidney injury. J Am Soc Nephrol 22:999–1006. CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Kikeri D, Pennell JP, Hwang KH, Jacob AI, Richman AV, Bourgoignie JJ (1986) Endotoxemic acute renal failure in awake rats. Am J Phys 250:F1098–F1106. CrossRefGoogle Scholar
  44. 44.
    Badr KF, Kelley VE, Rennke HG, Brenner BM (1986) Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int 30:474–480CrossRefPubMedCentralGoogle Scholar
  45. 45.
    Li T, Liu Y, Zhao J, Miao S, Xu Y, Liu K, Liu M, Wang G, Xiao X (2017) Aggravation of acute kidney injury by mPGES-2 down regulation is associated with autophagy inhibition and enhanced apoptosis. Sci Rep 7:10247. CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Inscho EW, Carmines PK, Navar LG (1990) Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists. Am J Phys 259:F157–F163. CrossRefGoogle Scholar
  47. 47.
    Edwards RM (1985) Effects of prostaglandins on vasoconstrictor action in isolated renal arterioles. Am J Phys 248:F779–F784. CrossRefGoogle Scholar
  48. 48.
    Abramovitz M, Adam M, Boie Y, Carriere M, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM, Belley M, Gallant M, Dufresne C, Gareau Y, Ruel R, Juteau H, Labelle M, Ouimet N, Metters KM (2000) The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 1483:285–293CrossRefPubMedCentralGoogle Scholar
  49. 49.
    Khan RZ, Badr KF (1999) Endotoxin and renal function: perspectives to the understanding of septic acute renal failure and toxic shock. Nephrol Dial Transplant 14:814–818CrossRefPubMedCentralGoogle Scholar
  50. 50.
    Leach M, Hamilton LC, Olbrich A, Wray GM, Thiemermann C (1998) Effects of inhibitors of the activity of cyclo-oxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin: a comparison with dexamethasone. Br J Pharmacol 124:586–592. CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Tunctan B, Korkmaz B, Cuez T, Kemal Buharalioglu C, Sahan-Firat S, Falck J, Malik KU (2010) Contribution of vasoactive eicosanoids and nitric oxide production to the effect of selective cyclooxygenase-2 inhibitor, NS-398, on endotoxin-induced hypotension in rats. Basic Clin Pharmacol Toxicol 107:877–882. CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Azab AN, Kobal S, Rubin M, Kaplanski J (2005) Effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on cardiovascular alterations in endotoxemia. Cardiology 103:92–100. CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Reddy RC, Chen GH, Tateda K, Tsai WC, Phare SM, Mancuso P, Peters-Golden M, Standiford TJ (2001) Selective inhibition of COX-2 improves early survival in murine endotoxemia but not in bacterial peritonitis. Am J Physiol Lung Cell Mol Physiol 281:L537–L543. CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Staehr M, Madsen K, Vanhoutte PM, Hansen PB, Jensen BL (2011) Disruption of COX-2 and eNOS does not confer protection from cardiovascular failure in lipopolysaccharide-treated conscious mice and isolated vascular rings. Am J Physiol Regul Integr Comp Physiol 301:R412–R420. CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Doi K, Yuen PS, Eisner C, Hu X, Leelahavanichkul A, Schnermann J, Star RA (2009) Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 20:1217–1221. CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Gerber JG, Keller RT, Nies AS (1979) Prostaglandins and renin release: the effect of PGI2, PGE2, and 13,14-dihydro PGE2 on the baroreceptor mechanism of renin release in the dog. Circ Res 44:796–799CrossRefPubMedCentralGoogle Scholar
  57. 57.
    Franco-Saenz R, Suzuki S, Tan SY, Mulrow PJ (1980) Prostaglandin stimulation of renin release: independence of beta-adrenergic receptor activity and possible mechanism of action. Endocrinology 106:1400–1404. CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Ito S, Carretero OA, Abe K, Beierwaltes WH, Yoshinaga K (1989) Effect of prostanoids on renin release from rabbit afferent arterioles with and without macula densa. Kidney Int 35:1138–1144CrossRefPubMedCentralGoogle Scholar
  59. 59.
    Henrich WL, Campbell WB (1984) Relationship between PG and beta-adrenergic pathways to renin release in rat renal cortical slices. Am J Phys 247:E343–E348. CrossRefGoogle Scholar
  60. 60.
    Hackenthal E, Schwertschlag U, Seyberth HW (1980) Prostaglandins and renin release studies in the isolated perfused rat kidney. Prog Biochem Pharmacol 17:98–107PubMedPubMedCentralGoogle Scholar
  61. 61.
    Jensen BL, Schmid C, Kurtz A (1996) Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells. Am J Phys 271:F659–F669. CrossRefGoogle Scholar
  62. 62.
    Friis UG, Stubbe J, Uhrenholt TR, Svenningsen P, Nusing RM, Skott O, Jensen BL (2005) Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells. Am J Physiol Renal Physiol 289:F989–F997. CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Schmidt C, Hocherl K, Schweda F, Kurtz A, Bucher M (2007) Regulation of renal sodium transporters during severe inflammation. J Am Soc Nephrol 18:1072–1083. CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Doerschug KC, Delsing AS, Schmidt GA, Ashare A (2010) Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis. Crit Care 14:R24. CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Hilgenfeldt U, Kienapfel G, Kellermann W, Schott R, Schmidt M (1987) Renin-angiotensin system in sepsis. Clin Exp Hypertens A 9:1493–1504PubMedPubMedCentralGoogle Scholar
  66. 66.
    Ohtani R, Ohashi Y, Muranaga K, Itoh N, Okamoto H (1989) Changes in activity of the renin-angiotensin system of the rat by induction of acute inflammation. Life Sci 44:237–241CrossRefPubMedCentralGoogle Scholar
  67. 67.
    Todorov V, Muller M, Schweda F, Kurtz A (2002) Tumor necrosis factor-alpha inhibits renin gene expression. Am J Physiol Regul Integr Comp Physiol 283:R1046–R1051. CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Antonipillai I, Wang Y, Horton R (1990) Tumor necrosis factor and interleukin-1 may regulate renin secretion. Endocrinology 126:273–278. CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Burnier M, Waeber B, Aubert JF, Nussberger J, Brunner HR (1988) Effects of nonhypotensive endotoxemia in conscious rats: role of prostaglandins. Am J Phys 254:H509–H516. CrossRefGoogle Scholar
  70. 70.
    Nitescu N, DiBona GF, Grimberg E, Guron G (2010) Angiotensin II type 1 receptor antagonism attenuates abnormalities in dynamic renal blood flow autoregulation in rats with endotoxin-induced acute kidney injury. Kidney Blood Press Res 33:200–208. CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Nitescu N, Grimberg E, Guron G (2008) Low-dose candesartan improves renal blood flow and kidney oxygen tension in rats with endotoxin-induced acute kidney dysfunction. Shock 30:166–172. CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Heyman SN, Darmon D, Goldfarb M, Bitz H, Shina A, Rosen S, Brezis M (2000) Endotoxin-induced renal failure. I A role for altered renal microcirculation. Exp Nephrol 8:266–274. CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Risoe PK, Wang Y, Stuestol JF, Aasen AO, Wang JE, Dahle MK (2007) Lipopolysaccharide attenuates mRNA levels of several adenylyl cyclase isoforms in vivo. Biochim Biophys Acta 1772:32–39. CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Choi WI, Kwon KY, Seo JW, Beagle J, Quinn DA, Hales CA (2009) The role of phosphodiesterase 3 in endotoxin-induced acute kidney injury. BMC Infect Dis 9:80. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Institute of Experimental and Clinical Pharmacology and ToxicologyFriedrich-Alexander-Universität Erlangen-Nürnberg (FAU)ErlangenGermany
  2. 2.Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Poliklinik, Klinikum der Universität MünchenLudwig-Maximilians-Universität MünchenMunichGermany
  3. 3.Institute of PhysiologyUniversity of RegensburgRegensburgGermany

Personalised recommendations